1. Home
  2. CALM vs NUVL Comparison

CALM vs NUVL Comparison

Compare CALM & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cal-Maine Foods Inc.

CALM

Cal-Maine Foods Inc.

HOLD

Current Price

$82.43

Market Cap

4.2B

ML Signal

HOLD

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$104.83

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CALM
NUVL
Founded
1957
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
7.1B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
CALM
NUVL
Price
$82.43
$104.83
Analyst Decision
Buy
Strong Buy
Analyst Count
4
15
Target Price
$102.50
$135.00
AVG Volume (30 Days)
973.8K
598.4K
Earning Date
01-07-2026
10-30-2025
Dividend Yield
10.03%
N/A
EPS Growth
198.25
N/A
EPS
26.04
N/A
Revenue
$4,398,616,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.20
N/A
Revenue Growth
65.80
N/A
52 Week Low
$79.55
$55.54
52 Week High
$126.40
$112.88

Technical Indicators

Market Signals
Indicator
CALM
NUVL
Relative Strength Index (RSI) 37.22 53.02
Support Level $86.62 $100.42
Resistance Level $88.05 $107.14
Average True Range (ATR) 2.16 3.09
MACD -0.06 -0.66
Stochastic Oscillator 6.29 38.48

Price Performance

Historical Comparison
CALM
NUVL

About CALM Cal-Maine Foods Inc.

Cal-Maine Foods Inc produces and sells shell eggs. Its main market is the United States. The company's product portfolio contains nutritionally enhanced, cage-free, organic, and brown eggs. Cal-Maine Foods markets the shell eggs to a diverse group of customers, including grocery-store chains, club stores, and food service distributors. The company's brands are Egg-Land's, Land O' Lakes, Farmhouse, and 4-Grain. The Company has one reportable operating segment, which is the production, grading, packaging, marketing and distribution of shell eggs.

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Share on Social Networks: